SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Pansieri Jonathan)
 

Search: WFRF:(Pansieri Jonathan) > S100A9 amyloid grow...

S100A9 amyloid growth and S100A9 fibril-induced impairment of gamma oscillations in area CA3 of mouse hippocampus ex vivo is prevented by Bri2 BRICHOS

Andrade-Talavera, Yuniesky (author)
Neuronal Oscillations Laboratory, Center for Alzheimer Research, Departments of NVS and KBH, Karolinska Institutet, Solna, Sweden
Chen, Gefei (author)
Karolinska Institutet
Pansieri, Jonathan (author)
Umeå universitet,Institutionen för medicinsk kemi och biofysik
show more...
Arroyo-García, Luis Enrique (author)
Neuronal Oscillations Laboratory, Center for Alzheimer Research, Departments of NVS and KBH, Karolinska Institutet, Solna, Sweden
Toleikis, Zigmantas (author)
Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania
Smirnovas, Vytautas (author)
Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania
Johansson, Jan (author)
Karolinska Institutet
Morozova-Roche, Ludmilla (author)
Umeå universitet,Institutionen för medicinsk kemi och biofysik
Fisahn, André (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
Elsevier, 2022
2022
English.
In: Progress in Neurobiology. - : Elsevier. - 0301-0082 .- 1873-5118. ; 219
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The pro-inflammatory and highly amyloidogenic protein S100A9 is central to the amyloid-neuroinflammatory cascade in neurodegenerative diseases leading to cognitive impairment. Molecular chaperone activity of Bri2 BRICHOS has been demonstrated against a range of amyloidogenic polypeptides. Using a combination of thioflavin T fluorescence kinetic assay, atomic force microscopy and immuno electron microscopy we show here that recombinant Bri2 BRICHOS effectively inhibits S100A9 amyloid growth by capping amyloid fibrils. Using ex-vivo neuronal network electrophysiology in mouse brain slices we also show that both native S100A9 and amyloids of S100A9 disrupt cognition-relevant gamma oscillation power and rhythmicity in hippocampal area CA3 in a time- and protein conformation-dependent manner. Both effects were associated with Toll-like receptor 4 (TLR4) activation and were not observed upon TLR4 blockade. Importantly, S100A9 that had co-aggregated with Bri2 BRICHOS did not elicit degradation of gamma oscillations. Taken together, this work provides insights on the potential influence of S100A9 on cognitive dysfunction in Alzheimer's disease (AD) via gamma oscillation impairment from experimentally-induced gamma oscillations, and further highlights Bri2 BRICHOS as a chaperone against detrimental effects of amyloid self-assembly.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Keyword

Amyloid
Bri2 BRICHOS
Gamma oscillations
Neurodegeneration
S100A9

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view